Key Points
Question
Is the risk of ventricular tachyarrhythmia similar between women and men with an implantable cardioverter-defibrillator for primary prevention?
Findings
In this cohort study of 4506 patients with an implantable cardioverter-defibrillator, women and patients with nonischemic cardiomyopathy displayed a significantly lower risk of first and recurrent life-threatening ventricular tachyarrhythmia events than men. In both cardiomyopathy types, risk of ventricular tachyarrhythmia remained significantly higher than risk of death without prior ventricular tachyarrhythmia for women and men, indicating a potential benefit of a primary prevention implantable cardioverter-defibrillator regardless of sex.
Meaning
Findings suggest that risk of ventricular tachyarrhythmia differs between men and women and by underlying cardiomyopathy, indicating a need for sex-specific risk assessment for primary prevention cardioverter-defibrillator implantation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.